Fengze Wang

709 total citations
7 papers, 96 citations indexed

About

Fengze Wang is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Fengze Wang has authored 7 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in Fengze Wang's work include SARS-CoV-2 and COVID-19 Research (4 papers), Viral gastroenteritis research and epidemiology (2 papers) and COVID-19 Clinical Research Studies (2 papers). Fengze Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Viral gastroenteritis research and epidemiology (2 papers) and COVID-19 Clinical Research Studies (2 papers). Fengze Wang collaborates with scholars based in China, Czechia and Hong Kong. Fengze Wang's co-authors include Qingrui Huang, Jinghua Yan, Siyu Tian, Kai Ji, George F. Gao, Wenjie Tan, Junfeng Hao, Baoying Huang, Zhou Tong and Shuguang Tan and has published in prestigious journals such as Nature Communications, EBioMedicine and Emerging Microbes & Infections.

In The Last Decade

Fengze Wang

6 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengze Wang China	4	72	37	20	18	17	7	96
Anne P. Werner United States	4	62 0.9×	35 0.9×	12 0.6×	15 0.8×	16 0.9×	6	115
Yuxia Bo Canada	8	124 1.7×	48 1.3×	23 1.1×	22 1.2×	13 0.8×	14	168
Shan-Lu Liu United States	3	160 2.2×	39 1.1×	17 0.8×	15 0.8×	29 1.7×	3	180
Yukari Itakura Japan	7	57 0.8×	22 0.6×	10 0.5×	22 1.2×	10 0.6×	24	106
Sandro Halwe Germany	6	101 1.4×	39 1.1×	17 0.8×	47 2.6×	15 0.9×	7	144
Esther A. Bondzie United States	6	88 1.2×	19 0.5×	35 1.8×	13 0.7×	20 1.2×	11	125
Johnstone Tcheou United States	4	51 0.7×	46 1.2×	24 1.2×	10 0.6×	20 1.2×	5	96
Nikesh Tailor Canada	8	87 1.2×	45 1.2×	9 0.5×	32 1.8×	10 0.6×	18	149
Patryk Aftanas Canada	4	112 1.6×	29 0.8×	14 0.7×	24 1.3×	12 0.7×	7	153
Ruxia Ding China	5	140 1.9×	31 0.8×	19 0.9×	16 0.9×	21 1.2×	7	158

Countries citing papers authored by Fengze Wang

Since Specialization

Citations

This map shows the geographic impact of Fengze Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengze Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengze Wang more than expected).

Fields of papers citing papers by Fengze Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengze Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengze Wang. The network helps show where Fengze Wang may publish in the future.

Co-authorship network of co-authors of Fengze Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengze Wang. A scholar is included among the top collaborators of Fengze Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengze Wang. Fengze Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ji, C., Siyu Tian, Fengze Wang, et al.. (2025). Neutralizing antibodies against Chikungunya virus and structural elucidation of their mechanism of action. Nature Communications. 16(1). 9682–9682. 1 indexed citations

2.

Jia, Zijing, Meng Wang, Lingling Nie, et al.. (2025). Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests. npj Vaccines. 10(1). 55–55.

3.

Shi, Rui, Jiawei Zeng, Ling Xu, et al.. (2022). A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core. EBioMedicine. 85. 104297–104297. 18 indexed citations

4.

Wang, Fengze, Li Li, Yang Dou, et al.. (2022). Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants. Emerging Microbes & Infections. 11(1). 548–551. 9 indexed citations

5.

Huang, Qingrui, Kai Ji, Siyu Tian, et al.. (2021). A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nature Communications. 12(1). 776–776. 56 indexed citations

6.

Huang, Qingrui, Kai Ji, Siyu Tian, et al.. (2021). Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nature Communications. 12(1). 2355–2355. 3 indexed citations

7.

Tian, Siyu, Kai Ji, Meng Wang, et al.. (2021). Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice. Cell Discovery. 7(1). 91–91. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact